Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study) | Zendy

Anne L. Schafer | Zendy; Deborah E. Sellmeyer | Zendy; Ann V. Schwartz | Zendy; Clifford J. Rosen | Zendy; Eric Vittinghoff | Zendy; Lisa Palermo | Zendy; John P. Bilezikian | Zendy; Dolores Shoback | Zendy; Dennis M. Black | Zendy

Open Access

Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study)

Author(s) -

Anne L. Schafer,

Deborah E. Sellmeyer,

Ann V. Schwartz,

Clifford J. Rosen,

Eric Vittinghoff,

Lisa Palermo,

John P. Bilezikian,

Dolores Shoback,

Dennis M. Black

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-0587

Subject(s) - endocrinology , medicine , osteocalcin , parathyroid hormone , osteoporosis , adiponectin , bone remodeling , leptin , obesity , chemistry , insulin resistance , alkaline phosphatase , calcium , enzyme , biochemistry

The undercarboxylated form of the osteoblast-secreted protein osteocalcin has favorable effects on fat and glucose metabolism in mice. In human subjects, cross-sectional studies suggest a relevant association.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research